Lipolytic Effects of GH in Hypopituitary Patients in Vivo

NCT02782208 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Hypopituitarism
Insulin Resistance
Endocrine System Diseases
Glucose Metabolism Disorders
Metabolic Diseases
Pituitary Diseases
Brain Diseases

Interventions

DRUG: Acipimox
DRUG: Placebo
DRUG: GH substitution
OTHER: GH pause

Sponsor

University of Aarhus